Trial
NCT00997581
Apremilast Therapy for Acute Gouty Arthritis
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Celgene Corporation
Condition
Acute Gout
Intervention
apremilast
Why stopped
Colaborator withdrew support.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-02